Avoro Capital Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Avoro Capital Advisors’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$196M	Buy
2025 Q1	$108M	Hold
2024 Q4	$150M	Hold
2024 Q3	$140M	Buy
2024 Q2	$122M	Buy
2024 Q1	$130M	Hold
2023 Q4	$156M	Buy
2023 Q3	$114M	Buy
2023 Q2	$88M	Buy